3,6-Dichloro-4,5-dimethylpyridazine

Catalog No. :
ACRLZW317
CAS No. :
34584-69-5
Molecular Formula :
C6H6Cl2N2
Molecular Weight :
177.03

IUPAC Name:3,6-dichloro-4,5-dimethylpyridazine

3,6-Dichloro-4,5-dimethylpyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$58.00Login to see priceIn stockIn stock
100g98%$226.00Login to see priceIn stockIn stock
500g98%$871.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6-Dichloro-4,5-dimethylpyridazine
IUPAC Name3,6-dichloro-4,5-dimethylpyridazine
MDL No.MFCD00067745
Molecular FormulaC6H6Cl2N2
Molecular Weight177.03
SMILESCC1=C(C)C(Cl)=NN=C1Cl
InChI KeyRUVVGCRPPJVNMC-UHFFFAOYSA-N
Synonym3,6-Dichloro-4,5-dimethylpyridazine | 34584-69-5 | 3,6-dichloro-4,5-dimethyl-pyridazine | MFCD00067745 | PYRIDAZINE, 3,6-DICHLORO-4,5-DIMETHYL- | SCHEMBL581530 | AMY6755 | DTXSID80611214 | RUVVGCRPPJVNMC-UHFFFAOYSA-N | 3,6-Dichlor-4,5-dimethylpyridazin | BBL101907 | STL555704 |
CAS No.34584-69-5
PubChem CID21187505

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRLZW317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRLZW317 route compound structure diagram
    ACRLZW31734584-69-5 In Stock
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  4. Then
  5. ACRLZW317 route product structure diagram
    ACRLZW31734584-69-5 In Stock
Inquiry

2. ACRLZW317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRLZW317 route product structure diagram
    ACRLZW31734584-69-5 In Stock
Inquiry

Comments (0)